Brain Distribution of a Panel of Epidermal Growth Factor Receptor Inhibitors Using Cassette Dosing in Wild-Type and Abcb1/Abcg2-Deficient Mice
Minjee Kim(Massachusetts Eye and Ear Infirmary), William F. Elmquist(University of Minnesota), Jann N. Sarkaria(Mayo Clinic in Arizona), Afroz S. Mohammad(University of Minnesota), James Fisher(Children’s Minnesota - St. Paul Hospital), Janice K. Laramy(University of Minnesota), Surabhi Talele(University of Minnesota)
Cited by 49
Related Papers
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
|Neuro-Oncology|2008|387
Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177
|Journal of Clinical Oncology|2008|275
Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel
|Molecular Cancer Therapeutics|2007|203
p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells
|Neuro-Oncology|2012|187
The Role of the Breast Cancer Resistance Protein (ABCG2) in the Distribution of Sorafenib to the Brain
|Journal of Pharmacology and Experimental Therapeutics|2010|159